semaglutide south carolina SC Medicaid program to stop covering expensive weight loss drugs for obesity • SC Daily Gazette Ozempic® (semaglutide) GLP-1 RA for

Some healthcare providers may prescribe both off-label in select cases, but this requires careful patient selection, comprehensive cardiovascular screening, and close monitoring for additive side effects including increased heart rate, blood pressure changes, and gastrointestinal symptoms

A 2023 study analysing social media posts and a second group of participants (no mice this time) who took semaglutide or tirzepatide found that people who took these weight loss drugs reported drinking less alcohol generally, and on occasions where they binge drank

Proper management of people with obesity during the COVID-19 pandemic

After a comprehensive safety review, the MHRA concluded that available proofs does not support a causal connection between GLP-1 medicines and depression or suicidal behaviour

Just like high blood pressure and high cholesterol, where we do not stop medications once a person reaches the target, it is not recommended to stop GLP-1 medications once a person has reached their goal weight," says Cynthia Odogwu, M.D